Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Berlin - Delayed Quote • EUR Novo Nordisk A/S (NOV.BE) Follow Add holdings 54.14 -1.15 (-2.08%) At close: April 25 at 4:52:07 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for NOV.BE 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: NOV.BE View More All News Press Releases SEC Filings How tariffs impact pharma stocks Novo Nordisk wins case to kick knockoff Ozempic off the market, but it may not last FDA free to pursue semaglutide compounders after latest court ruling Why Novo Nordisk Stock Dropped Today The Best Stock to Buy With Less Than $60 in the Market Sell-Off Trending tickers: Alphabet, Intel, Meta, Novo Nordisk and WPP Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock? Novo Nordisk's stellar Wegovy-fuelled run of hiking sales guidance could be ending Novo Nordisk Investors Just Got Terrible News. Should You Sell the Stock? Is Eli Lilly Stock a Buy? Novo Nordisk Pops After Leapfrogging Eli Lilly With An Obesity Pill